Tue, February 15, 2011
[ Tue, Feb 15th 2011 ] - Market Wire
Belo Sun Mobilizes a Sixth Drill Rig and Initiate .. uth Block of the Volta Grande Gold Project Brazil
[ Tue, Feb 15th 2011 ] - Market Wire
CONMED Corporation Launches New Products at 2011 .. American Academy of Orthopaedic Surgeons Meeting
[ Tue, Feb 15th 2011 ] - Market Wire
ArthroCare Receives FDA Clearance for Spartan 5.5 Needled Suture Implant
[ Tue, Feb 15th 2011 ] - Market Wire
Covidien to Launch TurboHawka" Plaque Excision System for Small Vessels
[ Tue, Feb 15th 2011 ] - Market Wire
Amedisys Welcomes Julie L. Lewis as Vice President of Health Policy and Government Relations
[ Tue, Feb 15th 2011 ] - Market Wire
Compugen Ltd. Reports Fourth Quarter and Calendar 2010 Financial Results
Mon, February 14, 2011
[ Mon, Feb 14th 2011 ] - Market Wire
The Law Office of Abe Shainberg Launches an Inves .. es of Fiduciary Duty by the Board of Emergency Me
[ Mon, Feb 14th 2011 ] - Market Wire
Kendall Law Group Investigates Emergency Medical Services Corporation Acquisition for Shareholders
[ Mon, Feb 14th 2011 ] - Market Wire
Corgenix Reports Second Quarter Fiscal 2011 Financial Results
[ Mon, Feb 14th 2011 ] - Market Wire
Orthovita Schedules Conference Call for Fourth Qu .. Year-End 2010 Financial Results and 2011 Guidance
[ Mon, Feb 14th 2011 ] - Market Wire
CytRx to Receive Shares of ADVENTRX Pharmaceuticals in Exchange for 19% Stake in SynthRx
[ Mon, Feb 14th 2011 ] - Market Wire
Health Net Announces Annual Investor Day to Be Held in New York on February 17, 2011
[ Mon, Feb 14th 2011 ] - Market Wire
BrainStorm Receives FDA Orphan Drug Designation f .. in the Treatment of Amyotrophic Lateral Sclerosis
[ Mon, Feb 14th 2011 ] - Market Wire
Call Genie Inc. Announces Engagement of Wolverton .. Connection With $5,000,000 Convertible Debenture
[ Mon, Feb 14th 2011 ] - Market Wire
Oncolytics Biotech® Inc. Meets Primary Endpo .. of U.S. Phase 2 Pancreatic Cancer Clinical Trial
[ Mon, Feb 14th 2011 ] - Market Wire
BioSante Pharmaceuticals, Inc. To Present LibiGel .. ety Study Update at BIO CEO & Investor Conference
[ Mon, Feb 14th 2011 ] - Market Wire
Inspire Announces Date for Conference Call and We .. er and Full Year 2010 Financial Results and Provi
[ Mon, Feb 14th 2011 ] - Market Wire
AVEO Pharmaceuticalsa? Tivozanib Clinical Data Fe .. at the 2011 ASCO Genitourinary Cancers Symposium
[ Mon, Feb 14th 2011 ] - Market Wire
ArthroCare Reports Fourth Quarter and Full Year 2010 Financial Results
[ Mon, Feb 14th 2011 ] - Market Wire
Medisafe 1 Technologies and McKesson Corp Have Em .. Preliminary Discussions for Potential Cooperation
[ Mon, Feb 14th 2011 ] - Market Wire
Geron to Present at 13th Annual BIO CEO & Investor Conference
Fri, February 11, 2011
[ Fri, Feb 11th 2011 ] - Market Wire
49 Days Left - Kahn Swick & Foti, LLC and Former .. mind Investors With Large Financial Interests (Ov
[ Fri, Feb 11th 2011 ] - Market Wire
MEDWELL CAPITAL REPORTS 2010 YEAR-END RESULTS
[ Fri, Feb 11th 2011 ] - Market Wire
Vertex Announces Webcasts of its Presentations at Two Investor Conferences
[ Fri, Feb 11th 2011 ] - Market Wire
Amedisys Announces Poster Presentation at the Ame .. Therapy Associationa?s Combined Sections Meeting
[ Fri, Feb 11th 2011 ] - Market Wire
ArthroCare Announces Fourth Quarter and Full Year .. s Release and Conference Call Dates and Announces
[ Fri, Feb 11th 2011 ] - Market Wire
Seniors Share Their Love Stories; Celebrate Love Both Early and Late in Life
[ Fri, Feb 11th 2011 ] - Market Wire
Abraham, Fruchter & Twersky, LLP Announces Filing .. Class Action Lawsuit against Mannkind Corporation
[ Fri, Feb 11th 2011 ] - Market Wire
Gilead Sciences vuelve a presentar a la FDA solic .. r©gimen de nico comprimido de Truvada® y TMC278
[ Fri, Feb 11th 2011 ] - Market Wire
American Learning Corporation Reports Third Quarter Results
[ Fri, Feb 11th 2011 ] - Market Wire
NPS Pharmaceuticals to Present at Leerink Swann Hot Topics in Therapeutics Roundtable Conference
[ Fri, Feb 11th 2011 ] - Market Wire
ImmunoCellular Therapeutics to Present at the 13th Annual BIO CEO & Investor Conference
[ Fri, Feb 11th 2011 ] - Market Wire
Inhibitex Receives Fast Track Designation for INX .. r the Treatment of Chronic Hepatitis C Infections
[ Fri, Feb 11th 2011 ] - Market Wire
Gilead Sciences deposita nuovamente la domanda di .. o presso la?ente statunitense preposto al control
[ Fri, Feb 11th 2011 ] - Market Wire
Gilead Sciences erneuert FDA-Zulassungsantrag fr .. Einzeltablettentherapie mit Truvada® und TMC278
[ Fri, Feb 11th 2011 ] - Market Wire
Gilead Sciences deponeert bij de FDA een nieuwe a .. engen van het regime van ©©n tablet Truvada® e
Thu, February 10, 2011
[ Thu, Feb 10th 2011 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES CEO INTERVIEW ON LEADING BUSINESS RADIO PROGRAM
[ Thu, Feb 10th 2011 ] - Market Wire
New AVERROES Data Demonstrate Investigational Api .. Reducing Stroke and Systemic Embolism in Patients
[ Thu, Feb 10th 2011 ] - Market Wire
CardioNet,Inc. Appoints Peter Ferola General Coun .. and Senior Vice President, Corporate Development
[ Thu, Feb 10th 2011 ] - Market Wire
Aradigm to Present at the 13th Annual Biotechnolo .. stry Organization (BIO) CEO & Investor Conference
[ Thu, Feb 10th 2011 ] - Market Wire
CompCare Announces Preliminary Revenue for Fourth Quarter 2010
[ Thu, Feb 10th 2011 ] - Market Wire
BioCryst Provides Corporate Update and Reports Fourth Quarter and Full Year 2010 Financial Results
[ Thu, Feb 10th 2011 ] - Market Wire
AVEO Pharmaceuticals, Inc. Announces Timing for 2 .. 10 Financial Results, Webcast and Conference Call
[ Thu, Feb 10th 2011 ] - Market Wire
University Clinic Heidelberg Introduces New TomoTherapy(R) TomoHD(TM) Radiation Therapy System
[ Thu, Feb 10th 2011 ] - Market Wire
Exelixis Announces February 22 Webcast of Its Fou .. Full Year 2010 Financial Results Conference Call
[ Thu, Feb 10th 2011 ] - Market Wire
Lilly CEO Says Industry, Public Policy Must Pave Way For Innovation
[ Thu, Feb 10th 2011 ] - Market Wire
Celgene Corporation to Present at ISI Groupa?s 1st Annual Global Positioning Summit
[ Thu, Feb 10th 2011 ] - Market Wire
Clinical Data, Inc. Reports Third Quarter Fiscal Year 2011 Operational and Financial Results
[ Thu, Feb 10th 2011 ] - Market Wire
Natus Medical Appoints John T. Buhler as President and COO
[ Thu, Feb 10th 2011 ] - Market Wire
Repligen Reports Third Quarter Fiscal Year 2011 Financial Results
[ Thu, Feb 10th 2011 ] - Market Wire
PolyMedix Initiates Phase 2 Clinical Trial with Novel Heptagonist, PMX-60056
Wed, February 9, 2011
[ Wed, Feb 09th 2011 ] - Market Wire
The Law Office of Joseph Klein is Investigating P .. Duty by the Board of RehabCare Group, Inc. in Co
[ Wed, Feb 09th 2011 ] - Market Wire
ArthroCare Announces Settlement of SEC Investigation
[ Wed, Feb 09th 2011 ] - Market Wire
Talecris Biotherapeutics Announces Teleconference .. t Information for Special Meeting of Shareholders
[ Wed, Feb 09th 2011 ] - Market Wire
Court Confirms Globus Device Infringes Medtronic Patents
[ Wed, Feb 09th 2011 ] - Market Wire
Poniard Pharmaceuticals Completes $1.9 Million Financing
[ Wed, Feb 09th 2011 ] - Market Wire
Herbalife Launches Dual Action Booster for Signature Protein Shake
[ Wed, Feb 09th 2011 ] - Market Wire
Humana Military Launches Mobile Web Site
[ Wed, Feb 09th 2011 ] - Market Wire
CORRECTING and REPLACING Affymax to Present at BIO CEO & Investor Conference
[ Wed, Feb 09th 2011 ] - Market Wire
Cubist Pharmaceuticals to Present at February Investor Conference
[ Wed, Feb 09th 2011 ] - Market Wire
BIOLASE Pays Off Entire $3 Million Debt Facility
[ Wed, Feb 09th 2011 ] - Market Wire
Miami HEAT Forward Juwan Howard and NBA Legend Bo .. ens Educational Campaign to Urge Local Teens to T
[ Wed, Feb 09th 2011 ] - Market Wire
D. Medical's Revolutionary "Spring Hybrid Patch" .. p Solution to be Officially Unveiled at ATTD 2011
[ Wed, Feb 09th 2011 ] - Market Wire
Cytokinetics Provides Update Regarding Omecamtiv Mecarbil Clinical Development Program
[ Wed, Feb 09th 2011 ] - Market Wire
ISTA Pharmaceuticals Announces Conference Call an .. urth Quarter and Full-Year 2010 Financial Results
Tue, February 8, 2011
[ Tue, Feb 08th 2011 ] - Market Wire
Microbix'; CEO Statement on Universal Vaccine
[ Tue, Feb 08th 2011 ] - Market Wire
Marina Biotech, Inc. to Present at The 13th Annual BIO CEO & Investor Conference
[ Tue, Feb 08th 2011 ] - Market Wire
ISTA Pharmaceuticals Announces XIBROM(TM) Shipments to Wholesalers to End on February 28, 2011
[ Tue, Feb 08th 2011 ] - Market Wire
Gilead Sciences Announces Notification of ANDA Filing for Tamiflu®
[ Tue, Feb 08th 2011 ] - Market Wire
ArQule, Inc. to Present at 13th Annual BIO CEO and Investor Conference
[ Tue, Feb 08th 2011 ] - Market Wire
Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock and Warrants
[ Tue, Feb 08th 2011 ] - Market Wire
XenoPort to Release Fourth Quarter and Year-End Financial Results on February 16, 2011
[ Tue, Feb 08th 2011 ] - Market Wire
Teva Invites Public to Listen to Its 2011 Investor Meeting Webcast
[ Tue, Feb 08th 2011 ] - Market Wire
Synergy Pharmaceuticals effectuera une pr©sentat .. la 13me conf©rence annuelle BIO CEO and Investor
[ Tue, Feb 08th 2011 ] - Market Wire
Synergy Pharmaceuticals auf der 13. BIO CEO and Investor Conference unter den Referenten
[ Tue, Feb 08th 2011 ] - Market Wire
PASOS PARA AYUDAR A QUE SU HIJO TENGA UNA SONRISA BRILLANTE
[ Tue, Feb 08th 2011 ] - Market Wire
Response Genetics, Inc. Announces Appointment of Company President
[ Tue, Feb 08th 2011 ] - Market Wire
Steps to Help Ensure Your Childa?s Bright Smile
[ Tue, Feb 08th 2011 ] - Market Wire
CytRx to Present at the 13th Annual BIO CEO & Investor Conference
Mon, February 7, 2011
[ Mon, Feb 07th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Emerge
[ Mon, Feb 07th 2011 ] - Market Wire
PolyMedix to Present at the 13th Annual BIO CEO Conference
[ Mon, Feb 07th 2011 ] - Market Wire
Liberty Metals & Mining Exercises Participation R .. 9 Million Financing for Further Proceeds of Up to
[ Mon, Feb 07th 2011 ] - Market Wire
00 A.M. EST
[ Mon, Feb 07th 2011 ] - Market Wire
FDA Approves Labeling Update for REYATAZ® (ataza .. lude Data Supporting the Recommended Adult Dose o
[ Mon, Feb 07th 2011 ] - Market Wire
Emeritus Signs Management Agreements with Columbia Pacific Advisors
[ Mon, Feb 07th 2011 ] - Market Wire
Tenet and Aetna Sign New National Multi-Year Agreement
[ Mon, Feb 07th 2011 ] - Market Wire
SANUWAVE Health Raises $4.1 Million
[ Mon, Feb 07th 2011 ] - Market Wire
FFF Enterprises Makes FluMist(R) by MedImmune a Key Addition to Its Flu Vaccine Portfolio
[ Mon, Feb 07th 2011 ] - Market Wire
2003 and ISO 9001:2008 Certifications
[ Mon, Feb 07th 2011 ] - Market Wire
Depomed's Reports Results of Phase 1 Trial of Twi .. ly Formulation of DM-1992 in Parkinson's Patients
[ Mon, Feb 07th 2011 ] - Market Wire
Salix Pharmaceuticals and Progenics Pharmaceutica .. nounce Worldwide License Agreement for RELISTOR®
[ Mon, Feb 07th 2011 ] - Market Wire
Progenics Pharmaceuticals and Salix Pharmaceutica .. nounce Worldwide License Agreement for RELISTOR®
[ Mon, Feb 07th 2011 ] - Market Wire
Proactive Interventions Reduce Hospital Admissions and Readmissions, Achieve Cost Savings
Sun, February 6, 2011
[ Sun, Feb 06th 2011 ] - Market Wire
Helix BioPharma Corp. Receives FDA IND Approval t .. ical Study With Its Lung Cancer Drug Candidate L-
Fri, February 4, 2011
[ Fri, Feb 04th 2011 ] - Market Wire
BG Medicine Announces Pricing of Initial Public Offering
[ Fri, Feb 04th 2011 ] - Market Wire
Universal American Corp. Schedules 2010 Fourth Qu .. Results Release and Conference Call for Thursday,
[ Fri, Feb 04th 2011 ] - Market Wire
XenoPort Announces New Employment Inducement Awards
[ Fri, Feb 04th 2011 ] - Market Wire
DaVita to Acquire DSI Renal, Inc.
[ Fri, Feb 04th 2011 ] - Market Wire
Sirona Reports Fiscal 2011 First Quarter Results
[ Fri, Feb 04th 2011 ] - Market Wire
Abiomed to Ring NASDAQ Closing Bell; Signifying S .. Heart Month and Celebrating a Successful Quarter
[ Fri, Feb 04th 2011 ] - Market Wire
US FDA Assigns New PDUFA Date for BRILINTA (ticagrelor tablets)
[ Fri, Feb 04th 2011 ] - Market Wire
SurModics to Webcast Annual Meeting on February 7
[ Fri, Feb 04th 2011 ] - Market Wire
Abiomed Announces Survey Results and Launches National Heart Recovery Awareness Campaign
[ Fri, Feb 04th 2011 ] - Market Wire
Allana Potash Increases Previously Announced Bought Deal to $27,900,000
[ Fri, Feb 04th 2011 ] - Market Wire
Daxor Announces Publication of Research Article o .. r (BVA-100) to Accurately Diagnose Anemia in Pati
[ Fri, Feb 04th 2011 ] - Market Wire
Aetna Board of Directors Increases Shareholder Dividend and Authorizes Quarterly Payment
[ Fri, Feb 04th 2011 ] - Market Wire
Continucare Corporation Reports Increased Revenue and Net Income for Second Quarter of Fiscal 2011
[ Fri, Feb 04th 2011 ] - Market Wire
Life Technologies Announces Fourth Quarter and Fiscal Year 2010 Results
Thu, February 3, 2011
[ Thu, Feb 03rd 2011 ] - Market Wire
MEDNAX Earns $1.12 Per Share for 2010 Fourth Quarter
[ Thu, Feb 03rd 2011 ] - Market Wire
BioTeam, Life Technologies Launch Extended Services & Support for Torrent Server
[ Thu, Feb 03rd 2011 ] - Market Wire
Electromed, Inc. Second Quarter Earnings Call Scheduled for February 10, 2011
[ Thu, Feb 03rd 2011 ] - Market Wire
BIOLASE Receives CE Mark Approval for Waterlase(R) iPlus(TM) All-Tissue Laser
[ Thu, Feb 03rd 2011 ] - Market Wire
Will Geron & AEterna Zentaris Remain Healthcare "Winners"?
[ Thu, Feb 03rd 2011 ] - Market Wire
TomoTherapy to Announce Fourth Quarter Financial Results on Friday, February 18, 2011
[ Thu, Feb 03rd 2011 ] - Market Wire
Opinions on Gilead Sciences Inc. and GlaxoSmithKline plc -- A Look at R&D in the Health Industry
[ Thu, Feb 03rd 2011 ] - Market Wire
Cornerstone Therapeutics Appoints Chief Financial Officer
[ Thu, Feb 03rd 2011 ] - Market Wire
GSK and Theravance Announce Progression of LAMA/L .. ion Treatment Into Phase III Development for COPD
[ Thu, Feb 03rd 2011 ] - Market Wire
Implant Sciences Announces Force Protection Order Worth Over $200,000 to Customer in Europe
[ Thu, Feb 03rd 2011 ] - Market Wire
CONMED Corporation Announces Fourth Quarter and Full Year 2010 Financial Results
[ Thu, Feb 03rd 2011 ] - Market Wire
Hansen Medical and Philips Enter Agreements for t .. Applications of Fiber Optic Shape Sensing and Lo
[ Thu, Feb 03rd 2011 ] - Market Wire
Given Imaging Announces German Public Health Syst .. blish PillCam(R) SB Outpatient Reimbursement Code
[ Thu, Feb 03rd 2011 ] - Market Wire
Migraine Therapeutics Reviewed by NeuroInvestment
Wed, February 2, 2011
[ Wed, Feb 02nd 2011 ] - Market Wire
Radient Pharmaceuticals Completes Private Placeme .. ate Financing With Gross Proceeds of $7.5 Million
[ Wed, Feb 02nd 2011 ] - Market Wire
The Medicines Company to Announce Fourth Quarter .. Financial Results on Wednesday, February 16, 2011
[ Wed, Feb 02nd 2011 ] - Market Wire
Insulet Corporation to Report Fourth Quarter 2010 Financial Results on Tuesday, February 15, 2011
[ Wed, Feb 02nd 2011 ] - Market Wire
Mesa Uranium Acquires Uranium Leases
[ Wed, Feb 02nd 2011 ] - Market Wire
MEDNAX to Present at UBS 21st Annual Global Healthcare Services Conference
[ Wed, Feb 02nd 2011 ] - Market Wire
Assisted Living Concepts, Inc. Schedules Fourth Quarter Financial Results Conference Call
[ Wed, Feb 02nd 2011 ] - Market Wire
Dyer & Berens LLP Files Class Action Lawsuit on B .. sed the Common Stock of MannKind Corporation Betw
[ Wed, Feb 02nd 2011 ] - Market Wire
CardioNet, Inc. to Release Fourth Quarter and Full Year 2010 Earnings Results on February 17, 2011
[ Wed, Feb 02nd 2011 ] - Market Wire
ImmunoCellular Therapeutics Announces First Patient Enrolled In Its Phase II Trial of ICT-107
[ Wed, Feb 02nd 2011 ] - Market Wire
Harper Creek Drill Hole HC10-79 Extends Mineralization Beyond Previously Identified Eastern Limit
[ Wed, Feb 02nd 2011 ] - Market Wire
Aberdeen International to Release 2010 Fourth Qua .. er/Year-End Portfolio Update on February 16, 2011
[ Wed, Feb 02nd 2011 ] - Market Wire
Trinity Biotech Announces the Acquisition of Phoenix Biotech
[ Wed, Feb 02nd 2011 ] - Market Wire
NMT Medical Announces Plans to Begin Trading on OTCQB Marketplace
[ Wed, Feb 02nd 2011 ] - Market Wire
Novo Nordisk increased operating profit by 27% in 2010
Tue, February 1, 2011
[ Tue, Feb 01st 2011 ] - Market Wire
Five Star Quality Care, Inc. to Present at the UB .. ealthcare Services Conference on February 7, 2011
[ Tue, Feb 01st 2011 ] - Market Wire
Health Management Associates, Inc. to Present at the UBS 21st Annual Global Healthcare Conference
[ Tue, Feb 01st 2011 ] - Market Wire
Izard Nobel LLP Announces Class Action Lawsuit Against MannKind Corporation
[ Tue, Feb 01st 2011 ] - Market Wire
Arius3D Corp. Establishes a 3D Imaging Centre at the University of South Carolina
[ Tue, Feb 01st 2011 ] - Market Wire
Lightlake Therapeutics Takes Safer Approach to Obesity
[ Tue, Feb 01st 2011 ] - Market Wire
CORRECTING andREPLACING Biogen Idec Reports Full Year and Fourth Quarter 2010 Results
[ Tue, Feb 01st 2011 ] - Market Wire
Covidien Reports First-Quarter Results
[ Tue, Feb 01st 2011 ] - Market Wire
ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 25, 2011
[ Tue, Feb 01st 2011 ] - Market Wire
10 Canadian Tech Stocks to Watch in 2011
[ Tue, Feb 01st 2011 ] - Market Wire
European Union (EMEA) Approves Lead Therapeutics Drug From Global Health Ventures Inc.
[ Tue, Feb 01st 2011 ] - Market Wire
BIOLASE Announces Successful Launch of Waterlase( .. -Tissue Laser at Boston Yankee Dental Congress 36
[ Tue, Feb 01st 2011 ] - Market Wire
Rosetta Genomics Advances Development of Its Body .. ased Diagnostic Tests With Two New Collaborations
[ Tue, Feb 01st 2011 ] - Market Wire
Aoxing Pharmaceutical Company Appoints Bob Ai as Chief Financial Officer
[ Tue, Feb 01st 2011 ] - Market Wire
Transdel Pharmaceuticals Announces Exploration of Strategic Alternatives
Mon, January 31, 2011
[ Mon, Jan 31st 2011 ] - Market Wire
KCI neemt licentie op merk GRAFTJACKET voor wondverzorging van Wright Medical
[ Mon, Jan 31st 2011 ] - Market Wire
GATTEX® (teduglutida) cumple el criterio princip .. estudio fundamental de Fase 3 en pacientes adult
[ Mon, Jan 31st 2011 ] - Market Wire
Health Net Federal Services Re-Awarded Department .. y Based Outpatient Clinic Contract in Alamogordo,
[ Mon, Jan 31st 2011 ] - Market Wire
Wright Medical Group, Inc. Announces Expansion of Relationship with Kinetic Concepts, Inc.
[ Mon, Jan 31st 2011 ] - Market Wire
Humana Extends National Agreement to Offer Healthwaysa? SilverSneakers® Fitness Program
[ Mon, Jan 31st 2011 ] - Market Wire
CompCare Appoints Leading Healthcare Consultant, David Pitts, to its Board of Directors
[ Mon, Jan 31st 2011 ] - Market Wire
Sound Surgical Technologies to Promote Cytori's P .. ) System -- the Latest Innovation in Fat Grafting
[ Mon, Jan 31st 2011 ] - Market Wire
Covidien and Masimo Announce Extension of Royalty Agreement
[ Mon, Jan 31st 2011 ] - Market Wire
Repligen Announces Conference Call of Third Quarter Fiscal Year 2011 Results
[ Mon, Jan 31st 2011 ] - Market Wire
KCI concede in licenza il marchio GRAFTJACKET® d .. Wright Medical per la cura delle lesioni cutanee
[ Mon, Jan 31st 2011 ] - Market Wire
GATTEX® (Teduglutid) erreicht primren Wirksamkei .. 3-Studie mit erwachsenen Patienten mit Kurzdarmsy
[ Mon, Jan 31st 2011 ] - Market Wire
GATTEX® (teduglutide) Meets Primary Efficacy End .. Study in Patients with Adult Short Bowel Syndrome
[ Mon, Jan 31st 2011 ] - Market Wire
GATTEX® (teduglutide) soddisfa l'endpoint primar .. ruciale di fase 3 per i pazienti adulti affetti d
[ Mon, Jan 31st 2011 ] - Market Wire
GATTEX® (teduglutide) voldoet aan primair eindpu .. se 3 hoofdstudie in volwassen pati?nten met korte
Sun, January 30, 2011
[ Sun, Jan 30th 2011 ] - Market Wire
Dr. Reddya?s Provides Update on the Fexofenadine-Pseudoephedrine 24 Hour Litigation
[ Sun, Jan 30th 2011 ] - Market Wire
CORRECTING and REPLACING Wright Medical Group, In .. Host Fourth Quarter 2010 Earnings Conference Call
Fri, January 28, 2011
[ Fri, Jan 28th 2011 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES FOURTH QUARTER AND YEAR-END FINANCIALS
[ Fri, Jan 28th 2011 ] - Market Wire
Angiotech Pharmaceuticals, Inc. Obtains Court Ord .. ection with Previously Announced CCAA Proceedings
[ Fri, Jan 28th 2011 ] - Market Wire
FDA Approves Rituxan for First-Line Maintenance Use in Follicular Lymphoma
[ Fri, Jan 28th 2011 ] - Market Wire
GTSO Names John Shearer President and CEO
[ Fri, Jan 28th 2011 ] - Market Wire
Incyte to Report 2010 Financial Results and Provi .. Objectives and Financial Guidance on February 10
[ Fri, Jan 28th 2011 ] - Market Wire
Greatbatch, Inc. to Host Investor Day on March 24, 2011
Thu, January 27, 2011
[ Thu, Jan 27th 2011 ] - Market Wire
(NASDAQ: KERX) Rated a "BUY" by 5 Wall Street Firms
[ Thu, Jan 27th 2011 ] - Market Wire
PhysioSonics Completes Series B Funding
[ Thu, Jan 27th 2011 ] - Market Wire
Covidien entrega la plataforma de energa nmero 20.000 ForceTriadTM
[ Thu, Jan 27th 2011 ] - Market Wire
Tenet Announces Agreement with Keystone Mercy Health Plan
[ Thu, Jan 27th 2011 ] - Market Wire
RTI Biologics Schedules 2010 Fourth Quarter, Year .. End Earnings and Conference Call for Feb. 3, 2011
[ Thu, Jan 27th 2011 ] - Market Wire
Marina Biotech Announces Issuance of Patent Cover .. ng Peptide Technology From the Japanese Patent Of
[ Thu, Jan 27th 2011 ] - Market Wire
Celgene Reports Record Non-GAAP Fourth Quarter and Full Year 2010 Operating and Financial Results
[ Thu, Jan 27th 2011 ] - Market Wire
Emeritus and Columbia Pacific Advisors to Explore Opportunities For Senior Housing in China
[ Thu, Jan 27th 2011 ] - Market Wire
RXi Pharmaceuticals Announces Positive Initial Results in microRNA Therapeutics
[ Thu, Jan 27th 2011 ] - Market Wire
Patient Home Monitoring Announces Sales Pipeline Update
[ Thu, Jan 27th 2011 ] - Market Wire
Newly Published Data Demonstrates Caldolor® Sign .. Pain and Morphine Use in Post-Operative Patients
[ Thu, Jan 27th 2011 ] - Market Wire
Covidien levert 20.000ste ForceTriad energieplatform
[ Thu, Jan 27th 2011 ] - Market Wire
Covidien livre sa 20.000me plateforme ©nerg©tique ForceTriadTM
[ Thu, Jan 27th 2011 ] - Market Wire
IDC PARTICIPATES IN CANADIAN GOVERNMENT LED TRADE MISSION TO SAUDI ARABIA
Wed, January 26, 2011
[ Wed, Jan 26th 2011 ] - Market Wire
Covidien liefert das 20.000. Exemplar seiner ForceTriadTM-Energieplattform aus
[ Wed, Jan 26th 2011 ] - Market Wire
NeuroMetrix, Inc. Announces Date for 2010 Fourth Quarter Financial Results Conference Call
[ Wed, Jan 26th 2011 ] - Market Wire
NIS HOLDINGS CORP. Announces Relocation of Headquarters
[ Wed, Jan 26th 2011 ] - Market Wire
Radient Pharmaceuticals Receives NYSE Amex Notice of Delisting for Non-Compliance
[ Wed, Jan 26th 2011 ] - Market Wire
Covidien Delivers 20,000th ForceTriadTM Energy Platform
[ Wed, Jan 26th 2011 ] - Market Wire
Altra Investments and The Rohatyn Group Sell Controlling Stake in Infarmasa
[ Wed, Jan 26th 2011 ] - Market Wire
Teva to Acquire Corporacin Infarmasa
[ Wed, Jan 26th 2011 ] - Market Wire
Angiotech Pharmaceuticals, Inc. Announces Receipt of Notice of Termination From Rex Medical L.P.
[ Wed, Jan 26th 2011 ] - Market Wire
Wound Management Technologies Announces Secure eH .. luded During HIMSS 2011 Interoperability Showcase
[ Wed, Jan 26th 2011 ] - Market Wire
IDC ENTERS INTO CAD $3 MILLION STOCK PURCHASE GUARANTEE TERM SHEET
[ Wed, Jan 26th 2011 ] - Market Wire
Teva and APP Announce Launch of Generic Gemzar® Pursuant to Agreement
[ Wed, Jan 26th 2011 ] - Market Wire
St. Jude Medical Reports Fourth Quarter and Full-Year 2010 Results
[ Wed, Jan 26th 2011 ] - Market Wire
Gilead Sciences recibe notificacin de la FDA de n .. ud de autorizacin de comercializacin de nuevo frm
[ Wed, Jan 26th 2011 ] - Market Wire
Gilead Sciences ontvangt kennisgeving van U.S. FD .. voor de New Drug Application (Aanvraag voor nieuw

Corgenix to Host Conference Call to Discuss Second Quarter Results


//health-fitness.news-articles.net/content/2011/ .. ence-call-to-discuss-second-quarter-results.html
Published in Health and Fitness on Friday, February 4th 2011 at 16:55 GMT by Market Wire   Print publication without navigation


DENVER--([ BUSINESS WIRE ])--Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Monday, February 14, 2011, at 4:00 p.m. EST to discuss the Companya™s financial and operating performance for its quarter ended December 31, 2010, and the status of the Companya™s product development and marketing activities.

Corgenix invites all those interested in hearing managementa™s discussion of the quartera™s results to join the call by dialing:

U.S. attendees: (800) 862-9098
International attendees: +1 785 424 1051
Conference code is: CORGENIX

A question-and-answer session will follow the presentation by Corgenix management.

A replay will be available for 30 days following the call by dialing (800) 283-7928 for U.S. participants and +1 402 220 0866 for international participants.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the worlda™s only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at [ www.corgenix.com ].


Publication Contributing Sources